Literature DB >> 4420941

Cardiac murmurs and endocardial fibrosis associated with methysergide therapy.

D S Bana, P S MacNeal, P M LeCompte, Y Shah, J R Graham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4420941     DOI: 10.1016/0002-8703(74)90251-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  12 in total

Review 1.  Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Am J Ther       Date:  2009 Jul-Aug       Impact factor: 2.688

2.  Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease.

Authors:  C Y Chew; G M Ziady; M J Raphael; M Nellen; C M Oakley
Journal:  Br Heart J       Date:  1977-04

Review 3.  Heart failure induced by non-cardiac drugs.

Authors:  Lars Slørdal; Olav Spigset
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Mitral Valve Pathology.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-05-23       Impact factor: 2.931

5.  Drug-induced localized systemic scleroses.

Authors:  J R Graham
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

Review 6.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Pleuropulmonary fibrosis associated with chronic and excessive intake of ergotamine.

Authors:  B G Taal; E L Spierings; C Hilvering
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

Review 8.  Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review.

Authors:  Malcolm Steiger; W Jost; F Grandas; G Van Camp
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

Review 9.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

10.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Michael H Baumann; Richard B Rothman
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.